Postdoctoral researcher

id="offer-description" class="ecl-u-type-heading-2 ecl-u-mt-none ecl-u-mb-l">Offer Description Presentation of Sorbonne University : . To transmit knowledge, understand the world and meet the challenges of the 21st century, a new university was created on 1 January 2018, following the merger of Paris-Sorbonne University and Pierre and Marie Curie University. Sorbonne University is a multidisciplinary, research-intensive, world-class university. Based in the heart of Paris and present across the region, it is committed to student success and to addressing the scientific challenges of the 21st century. www.sorbonne-universite.fr . The team led by Dr Fabienne Foufelle, entitled "Metabolic diseases, diabetes and comorbidities", is Team 5 of the UMRS 1166 research unit (Inserm / Sorbonne University), integrated within the ICAN University Hospital Institute at Pitie-Salpetriere Hospital in Paris. The team's objective is to study the comorbidities of type 2 diabetes, such as insulin resistance and non-alcoholic fatty liver disease, and their relationship with lipid metabolism. There is strong continuity between basic and clinical research, thanks to the joint presence of researchers and clinicians (diabetology and hepatology departments at Pitie-Salpetriere Hospital). Location: UMRS 1166, 91 Bd de l’Hopital, 75013 PARIS, France. Mission : Define the optimized configuration of an “on-chip” device for adipocyte culture (*adipose tissue-on-chip*). Main activities : . Develop advanced c